Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.
Source:https://www.cnbc.com/2023/12/22/bristol-myers-squibb-to-buy-karuna-therapeutics.html
Source:https://www.cnbc.com/2023/12/22/bristol-myers-squibb-to-buy-karuna-therapeutics.html
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company
Subscribe now to keep reading and get access to the full archive.
© 2010-2022 Billy Tang
Supported By Growth SpeedUp Company